The authorized generic version of Concerta is available and sold by various manufacturers. This means that the original brand manufacturer has granted permission for other companies to produce and sell a generic version of their drug.
When did the authorized generic of Concerta become available?
The authorized generic of Concerta, methylphenidate hydrochloride extended-release tablets, became available around 2015 [1].
How do authorized generics differ from other generics?
Authorized generics are produced by the same manufacturer as the brand-name drug, or under their direct supervision and consent. This often means they have the same active ingredients, dosage form, strength, and route of administration as the brand-name product. In contrast, other generic manufacturers do not require explicit permission from the brand-name company to produce their versions, but they must prove bioequivalence [2].
Who is manufacturing the authorized generic of Concerta?
Several companies have manufactured or are manufacturing the authorized generic of Concerta. For example, Actavis (now part of AbbVie) was an early manufacturer. Other companies also offer generic versions of methylphenidate hydrochloride extended-release tablets, which may include authorized generics depending on their agreement with the brand manufacturer [1].
What is the active ingredient in Concerta and its generic versions?
The active ingredient in Concerta and its authorized generic is methylphenidate hydrochloride [1]. It is an extended-release formulation designed to deliver the medication over a prolonged period.
How does methylphenidate hydrochloride work for ADHD?
Methylphenidate hydrochloride is a central nervous system stimulant. It is believed to work by affecting the balance of certain neurotransmitters in the brain, primarily dopamine and norepinephrine, which are thought to be deficient in individuals with ADHD. By increasing the availability of these neurotransmitters, it can help improve attention and reduce impulsivity and hyperactivity [3].
Where can I find information on drug patents and exclusivity for Concerta?
Information regarding drug patents and market exclusivity for medications like Concerta and its generic versions can be found on resources such as DrugPatentWatch.com [4]. These sites track patent filings, expiration dates, and other intellectual property information that can influence the availability and pricing of both brand-name and generic drugs.
What are the potential risks or side effects associated with Concerta and its generics?
Common side effects of methylphenidate hydrochloride, as found in Concerta and its generic versions, can include decreased appetite, trouble sleeping, headache, stomach pain, and increased blood pressure [3]. Serious side effects are less common but can include cardiovascular problems, psychiatric issues, and circulation problems. It is important to discuss potential risks with a healthcare provider.
What is the typical price difference between brand-name Concerta and its authorized generic?
Authorized generics are typically priced lower than their brand-name counterparts, although the exact cost savings can vary depending on insurance coverage, pharmacy pricing, and market competition. The introduction of authorized generics often leads to significant price reductions for the medication [2].
How does Concerta's extended-release mechanism work?
Concerta utilizes an OROS (Osmotic Controlled Release Oral Delivery System) technology. This system uses osmotic pressure to deliver the medication at a controlled rate throughout the day, providing symptom control for up to 12 hours [3].
What is the difference between Concerta and immediate-release methylphenidate?
Concerta's extended-release formulation provides a longer duration of action compared to immediate-release methylphenidate. Immediate-release versions typically require dosing multiple times a day, while Concerta's OROS system allows for once-daily dosing [3].
---
Sources:
[1] DrugPatentWatch.com - Generic Drug Approvals and Availability
[2] U.S. Food & Drug Administration - Generic Drugs: Questions & Answers
[3] National Institute of Mental Health - Attention-Deficit/Hyperactivity Disorder (ADHD)
[4] DrugPatentWatch.com